New Zealand vs Singapore: Leprosy registered prevalence rate per 1 000 000 population
New Zealand
0.77
in 2022
Singapore
0.857
in 2024
New Zealand rank
91st
Singapore rank
89th
Leprosy registered prevalence rate per 1 000 000 population over time
- New Zealand
- Singapore
How they compare
Singapore currently reports 0.857 against 0.77 in New Zealand, a difference of 0.087.
That makes Singapore's figure about 1.1 times New Zealand's.
Across all 6 years both countries report, Singapore has been ahead every year.
New Zealand ranks 91st and Singapore ranks 89th of 169 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Zealand | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.3805 | 1.47 | 1.09 | Singapore |
| 2020s | 0.8725 | 1.2 | 0.33 | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher leprosy registered prevalence rate per 1 000 000 population, New Zealand or Singapore?
- Singapore, at 0.857 against 0.77 in New Zealand as of 2024.
- What is the difference in leprosy registered prevalence rate per 1 000 000 population between New Zealand and Singapore?
- 0.087, with Singapore ahead.
- How many years of comparable data are there for New Zealand and Singapore?
- 6 years are reported by both, from 2012 to 2022.
- How do New Zealand and Singapore rank globally for leprosy registered prevalence rate per 1 000 000 population?
- New Zealand ranks 91st and Singapore ranks 89th of 169 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Leprosy registered prevalence rate per 1 000 000 population. Statizoid refreshes it automatically from the source and publishes the full history for both places.